Connect Biopharma Holdings Limited

US$0.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CNTBHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (140.51%)
Biotechnology
Beta (5Y) (0.18)
PE TTM —
TSR TTM (57.39%)
Mkt cap US$45.89M
ROIC (88.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.694
(4.71%)
(85.77%)
Hold 4|2|10|2|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.01
0.01
0.01
0.01
(3.95%)
(7.88%)
(8.38%)
0.54%
Revenue$M
5.604
5.923
6.192
6.231
9.28%
14.43%
14.28%
14.58%
Peers (US$45.89M)
Cap (US$)
PE
46.60M
—
46.32M
—
Capital
TTM
5Y
10Y
Leveragex
2.301
(0.794)
(0.698)
EBIT/Intx
0.916
0.157
0.157
Own earn%
40.92
(152.19)
(94.78)
Sh yield%
25.49
37.59
40.23
Owners
Insiders/Inst%
9.83
47.68
Short interest%
4.88
SBC / revenue%
5.66
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
4–7
$1 testx
0.1
Incr. ROIC%
7